A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy

Journal of the Royal Society of Medicine

Volumn 106, Issue 3, 2013, Pages 87-95

  McDowell, Sarah E ^a   Thomas, Sarah K ^b   Coleman, Jamie J ^a,b,d   Aronson, Jeffrey K ^c   Ferner, Robin E ^b,d  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM; SODIUM; ANTIHYPERTENSIVE AGENT;

ADVERSE DRUG REACTION; ANTIHYPERTENSIVE THERAPY; CREATININE BLOOD LEVEL; DIURETIC THERAPY; HUMAN; HYPERTENSION; PATIENT MONITORING; PATIENT SAFETY; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; REVIEW; SODIUM BLOOD LEVEL; SYSTEMATIC REVIEW (TOPIC); DRUG MONITORING; STANDARD;

ANTIHYPERTENSIVE AGENTS; DRUG MONITORING; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC;

MLCS; MLOWN;

EID: 84877329403     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.2012.120137     Document Type: Review

References (28)

1. Ferner RE, Coleman J, Pirmohamed M, Constable SA, Rouse A. The quality of information on monitoring for haematological adverse drug reactions. Br J Clin Pharmacol 2005;60:448-51
2. McDowell SE, Ferner RE. Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: a systematic review. Drug Saf 2011;34:1049-59
3. Coleman JJ, McDowell SE, Evans SJ, Gill PS, Ferner RE. Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care. Br J Clin Pharmacol 2010;70:109-17
4. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001;135:703-10
5. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52
6. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004;351:585-92
7. Seedat YK, Croasdale MA, Milne FJ, et al. South African hypertension guideline 2006. S Afr Med J 2006;96:337-62
8. Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536
9. Smellie WS, Forth J, Coleman JJ, et al. Best practice in primary care pathology: review 6. J Clin Pathol 2007;60:225-34
10. Guidelines and Audit Implementation Network, Clinical Resource Efficiency Support Team. Guidelines on the Management of Hypertension - FAQs. 2007. see http://www. gain-ni.org/Publications/Guidelines/ crest_hypertension_guidelines-faq_s-july_2007.pdf (last checked 24 April 2012)
11. Rotaeche del Campo R, Aguirrezabala JJ, Balagué GL, et al. Clinical Practice Guidelines on Arterial Hypertension - 2007 Update. 2008. See http://www9.euskadi.net/sanidad/ osteba/datos/gpc_07_04_ingles.pdf (last checked 24 April 2012)
12. British Columbia Ministry of Health Services. Hypertension - Detection, Diagnosis and Management. 2008. See http:// www.bcguidelines.ca/pdf/hypertension.pdf (last checked 24 April 2012)
13. London and South East Regional Medicines Information Service, South West Medicines Information, Croydon Primary Care Trust. Suggestions for Drug Monitoring in Adults in Primary Care. 2008. See http://www.nelm.nhs.uk/ en/ NeLM-Area/Evidence/ Drug-Monitoring/Suggestions -for-Drug-Monitoring-in-Adults -in-Primary-Care/ (last checked 24 April 2012)
14. University of Michigan Health System. Essential Hypertension. 2009. See http://cme.med.umich.edu/pdf/ guideline/htn.pdf (last checked 24 April 2012)
15. Royal Infirmary of Edinburgh Renal Unit. How to Start an ACE Inhibitor. 2009. See http://renux.dmed.ed.ac.uk/ edren/Unitbits/ACEIstart.html (last checked 24 April 2012)
16. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009;32:3-107
17. Australian Heart Foundation. Guide to Management of Hypertension 2008 - Assessing and Managing Raised Blood Pressure in Adults Updated December 2010. See http://www.heartfoundation.org.au/ SiteCollectionDocuments/ HypertensionGuidelines2008to2010Update.pdf (last checked 24 April 2012)
18. Institute for Clinical Systems Improvement. Hypertension Diagnosis and Treatment. 2010. See http://www.icsi.org/ hypertension_4/hypertension_diagnosis_and_ treatment_4.html (last checked 24 April 2012)
19. Chiang CE, Wang TD, Li YH, et al. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension. J Formos Med Assoc 2010;109:740-73
20. Michigan Quality Improvement Consortium. Medical Management of Adults with Hypertension. 2011. See http:// www.uphpplus.com/docs%5CHypertensionMQIC.pdf (last checked 24 April 2012)
21. Rabi DM, Daskalopoulou SS, Padwal RS, et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011;27:415-33
22. National Institute for Health and Clinical Excellence. NICE Clinical Guideline 127. Hypertension: Management of Hypertension in Adults in Primary Care. 2011. See http:// www.nice.org.uk/nicemedia/live/13561/56007/56007.pdf (last checked 24 April 2012)
23. Scottish Intercollegiate Guidelines Network. SIGN 49: Hypertension in Older People. 2001. See http://www.sign.ac. uk/guidelines/fulltext/49/index.html (last checked 24 April 2012)
24. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40
25. French Haute Autorité de Santé. [Management of Adults with Eessential Hypertension - 2005 Update]. 2005. See http://www.has-sante.fr/portail/upload/docs/ application/pdf/2011-09/hta_2005_recommandations.pdf (last checked 24 April 2012)
26. Coleman JJ, McDowell SE, Ferner RE. Where does the evidence for guidelines come from? An example of monitoring for the adverse renal effects of ACE inhibitors. Drug Saf 2008;3:905-6
27. Sica DA. Antihypertensive therapy and its effects on potassium homeostasis. J Clin Hypertens (Greenwich) 2006;8:67-73
28. AGREE. Advancing the Science of Practice Guidelines. 2010. http://www.agreetrust.org/ (last checked 24 April 2012)